David P. Rosenbaum - 31 Aug 2022 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Issuer symbol
ARDX
Transactions as of
31 Aug 2022
Net transactions value
-$904
Form type
4
Filing time
01 Sep 2022, 19:04:45 UTC
Previous filing
24 Aug 2022
Next filing
23 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Purchase $1,856 +3,000 +3.4% $0.6188* 92,369 31 Aug 2022 By Wife F1, F2
transaction ARDX Common Stock Sale $2,760 -3,000 -3.2% $0.9201* 89,369 01 Sep 2022 By Wife F2
holding ARDX Common Stock 77,592 31 Aug 2022 Family Trust F3
holding ARDX Common Stock 302,458 31 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2022.
F2 The shares are directly held by the Reporting Person's wife.
F3 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.